{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:22:04Z","timestamp":1791105724980,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["NS59910"],"award-info":[{"award-number":["NS59910"]}]},{"name":"NIH","award":["NS65851"],"award-info":[{"award-number":["NS65851"]}]},{"name":"NIH","award":["GM103801"],"award-info":[{"award-number":["GM103801"]}]},{"name":"NIH","award":["GM48677"],"award-info":[{"award-number":["GM48677"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.nbd.2012.09.006","type":"journal-article","created":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T16:00:35Z","timestamp":1348416035000},"page":"30-41","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Nicotine-mediated improvement in l-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function"],"prefix":"10.1016","volume":"50","author":[{"given":"Maryka","family":"Quik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Mallela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Bordia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2012.09.006_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.09.006_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2012.09.006_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-0270(90)90139-7","article-title":"The use of 3H standards in 125I autoradiography","volume":"32","author":"Artymyshyn","year":"1990","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2012.09.006_bb0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bcp.2011.04.019","article-title":"An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants","volume":"82","author":"Baddick","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/13543784.2012.651457","article-title":"New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors","volume":"21","author":"Blandini","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.nbd.2012.09.006_bb0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.106.106997","article-title":"Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine","volume":"319","author":"Bordia","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1124\/jpet.108.140897","article-title":"Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease","volume":"327","author":"Bordia","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.109.162396","article-title":"Nicotinic receptor-mediated reduction in l-dopa-induced dyskinesias may occur via desensitization","volume":"333","author":"Bordia","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpsyc.63.8.907","article-title":"Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors","volume":"63","author":"Brody","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nbd.2012.09.006_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-381328-2.00005-5","article-title":"New approaches to therapy","volume":"98","author":"Brotchie","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/jpet.108.145292","article-title":"Desensitization of nicotinic acetylcholine receptors as a strategy for drug development","volume":"328","author":"Buccafusco","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2011.07.070","article-title":"Contribution of pre-synaptic mechanisms to l-DOPA-induced dyskinesia","volume":"198","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.09.006_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0079-6123(08)00922-9","article-title":"Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias","volume":"172","author":"Carta","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2012.09.006_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.tins.2007.03.005","article-title":"Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia","volume":"30","author":"Cenci","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0079-6123(10)83011-0","article-title":"Maladaptive striatal plasticity in l-DOPA-induced dyskinesia","volume":"183C","author":"Cenci","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2012.09.006_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.conb.2008.01.004","article-title":"Advances in understanding l-DOPA-induced dyskinesia","volume":"17","author":"Cenci","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0090","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","article-title":"Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice","volume":"23","author":"Champtiaux","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0095","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/npp.2011.8","article-title":"Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism","volume":"36","author":"Dao","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2012.09.006_bb0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates l-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.09.006_bb0105","series-title":"A stereotaxic atlas of the brain of the squirrel monkey (Saimiri sciureus)","author":"Emmers","year":"1963"},{"key":"10.1016\/j.nbd.2012.09.006_bb0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","article-title":"The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy","volume":"87","author":"Eskow","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2012.09.006_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/syn.20630","article-title":"The role of the dorsal raphe nucleus in the development, expression, and treatment of l-dopa-induced dyskinesia in hemiparkinsonian rats","volume":"63","author":"Eskow","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2012.09.006_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0079-6123(08)00918-7","article-title":"Serotonin receptors as potential targets for modulation of nicotine use and dependence","volume":"172","author":"Fletcher","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2012.09.006_bb0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0130","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bcp.2007.07.032","article-title":"The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum","volume":"74","author":"Grady","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0135","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mds.23669","article-title":"Milestones in Parkinson's disease \u2014 clinical and pathologic features","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.09.006_bb0140","first-page":"13","article-title":"Brain monoamines and parkinsonism","author":"Hornykiewicz","year":"1975","journal-title":"Natl. Inst. Drug Abuse Res. Monogr. Ser."},{"key":"10.1016\/j.nbd.2012.09.006_bb0145","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.2_Suppl_2.S2","article-title":"Biochemical aspects of Parkinson's disease","volume":"51","author":"Hornykiewicz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2012.09.006_bb0150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.111.182949","article-title":"Nicotine reduces l-Dopa-induced dyskinesias by acting at {beta}2 nicotinic receptors","volume":"338","author":"Huang","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0155","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuropharm.2010.12.032","article-title":"Nicotinic receptor agonists decrease l-dopa-induced dyskinesias most effectively in moderately lesioned parkinsonian rats","volume":"60","author":"Huang","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.09.006_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.184093","article-title":"Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?","volume":"339","author":"Huot","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0165","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00702-011-0698-2","article-title":"Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation","volume":"118","author":"Iravani","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.nbd.2012.09.006_bb0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of l-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0175","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2012.09.006_bb0180","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2012.09.006_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2008.10.016","article-title":"Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats","volume":"600","author":"Levin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0190","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/jpet.111.183525","article-title":"Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats","volume":"338","author":"Levin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0195","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/mol.65.6.1333","article-title":"Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release","volume":"65","author":"Luetje","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00213-006-0441-0","article-title":"Guidelines on nicotine dose selection for in vivo research","volume":"190","author":"Matta","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2012.09.006_bb0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.105.012773","article-title":"Decrease in alpha3*\/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage","volume":"68","author":"McCallum","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0210","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1471-4159.2005.03610.x","article-title":"Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates","volume":"96","author":"McCallum","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.09.006_bb0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2012.09.006_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.09.006_bb0225","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2012.09.006_bb0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0250","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/pr.110.003269","article-title":"{alpha}6{beta}2* and {alpha}4{beta}2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease","volume":"63","author":"Quik","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2012.09.006_bb0255","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1523\/JNEUROSCI.21-15-05494.2001","article-title":"Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey","volume":"21","author":"Quik","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0260","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0306-4522(02)00106-9","article-title":"Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage","volume":"112","author":"Quik","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.09.006_bb0265","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/mol.63.5.1169","article-title":"Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice","volume":"63","author":"Quik","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0270","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ana.21203","article-title":"Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys","volume":"62","author":"Quik","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0275","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2011.06.001","article-title":"Role of alpha6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders","volume":"82","author":"Quik","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuropharm.2012.04.029","article-title":"Role for alpha6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice","volume":"63","author":"Quik","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.09.006_bb0285","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/mds.23714","article-title":"Milestones in Parkinson's disease therapeutics","volume":"26","author":"Rascol","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.09.006_bb0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(88)91560-0","article-title":"Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats","volume":"450","author":"Robinson","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2012.09.006_bb0295","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves l-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.09.006_bb0300","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1124\/mol.65.6.1526","article-title":"Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice","volume":"65","author":"Salminen","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-381328-2.00006-7","article-title":"Surgical approach to l-dopa-induced dyskinesias","volume":"98","author":"Sankar","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2008.10.005","article-title":"Neurobiology and treatment of Parkinson's disease","volume":"30","author":"Schapira","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0315","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.09.006_bb0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pneurobio.2011.10.005","article-title":"Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease","volume":"96","author":"Sgambato-Faure","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0325","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3565(25)13058-9","article-title":"Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals","volume":"253","author":"Snyder","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2012.09.006_bb0330","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1523\/JNEUROSCI.07-06-01648.1987","article-title":"Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage","volume":"7","author":"Stachowiak","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0335","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/mds.10183","article-title":"The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys","volume":"17","author":"Tan","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.09.006_bb0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","article-title":"Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons","volume":"5","author":"Threlfell","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2012.09.006_bb0345","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2011.08.038","article-title":"Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia","volume":"195","author":"Timofeeva","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2012.09.006_bb0350","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/mds.23695","article-title":"Milestones in research on the pathophysiology of Parkinson's disease","volume":"26","author":"Wichmann","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2012.09.006_bb0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(00)00005-4","article-title":"Presynaptic nicotinic receptors modulating dopamine release in the rat striatum","volume":"393","author":"Wonnacott","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2004.12.002","article-title":"Nicotine: from molecular mechanisms to behaviour","volume":"5","author":"Wonnacott","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0365","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/syn.20645","article-title":"Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats","volume":"63","author":"Zaniewska","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2012.09.006_bb0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/syn.20756","article-title":"Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment","volume":"64","author":"Zaniewska","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2012.09.006_bb0375","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archneur.1984.04050190062015","article-title":"Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism","volume":"41","author":"Zigmond","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2012.09.006_bb0380","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0166-2236(90)90112-N","article-title":"Compensations after lesions of central dopaminergic neurons: some clinical and basic implications","volume":"13","author":"Zigmond","year":"1990","journal-title":"Trends Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112003208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112003208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:06:31Z","timestamp":1744185991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112003208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":76,"alternative-id":["S0969996112003208"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2012.09.006","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}